Varian Debuts BioStatic™ NMR Probe for Protein Applications
Complete the form below to unlock access to ALL audio articles.
Varian, Inc. has extended its offerings for bio-solids applications research by introducing the BioStatic™ nuclear magnetic resonance probe designed to determine the molecular structures of proteins and other biomolecules in a solid state.
Bio-solids NMR experiments allow access to 70% of all cellular proteins, such as membrane proteins, that are considered solids because they are not free floating in intracellular fluid.
These analyses can provide researchers with unparalleled insight into proteins and biomarker molecules associated with a wide variety of diseases.
Varian's BioStatic probe incorporates patent pending ultra-low E-field coil technology to reduce unwanted heating by up to 94% compared to a standard solenoid coil design probe, and enables experiments to be run up to 5x faster than competitive offerings.
Low transfer of heat to the sample is important to researchers because heating can alter or destroy valuable biological solids samples.
"Membrane proteins are of considerable interest to our customers because they represent approximately 65 percent of current drug targets," said Martin O'Donoghue, senior vice president of Scientific Instruments, Varian, Inc.
"The BioStatic probe is another product in our information rich detection (IRD) portfolio that demonstrates the continuing innovation of our NMR research and development team."
